This cluster aims to focus on the use of medicines and devices in older people. Medicines and devices have considerable potential to significantly improve outcomes and quality of life in older people. However, conversely, older people are particularly susceptible to the adverse effects of medicine and devices.
Within this cluster we will aim to develop systems to ensure the safe and effective use of both medicines and devices.
For more information about our Medicines and Devices Ageing cluster, contact cluster lead Ian Maidment. Email: email@example.com
Quality of life of the recipients of medicines and devices in ageing, and their carers
Interaction of biomedical polymers with living biological systems
Developing bioactive materials that help the body heal
Extension of the Gaussian Process formalism to model complex output distributions utilizing a sound experimental design strategy
Role of the pharmacist within both primary and secondary care
Drug delivery systems to improve the efficacy of a drug
Development of in-vitro CNS barrier systems, through tissue engineering approaches, to investigate targeted drug delivery to the CNS
Development of orally disintegrating tablets (ODT)
Click HERE to view our Medicines and Devices in Ageing cluster members and their research interests in healthy ageing.
Update January 2015
Shocking rise in dementia patients on ‘zombie’ drugs
Vitamin E taken further
The fight against MRSA
Fibre-optic implant could monitor wounds for infection
Ian Maidment is a senior lecturer in clinical pharmacy. His research interest is medication safety in dementia and mental health, and he has published widely in this field.